Wolverine Trading, LLC Ultragenyx Pharmaceutical Inc. Put Options Transaction History

Wolverine Trading, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2023 Aug 23, 2023	BUY	$37.35 - $52.15 $33,615 - $46,935	900 Added 14.06%	7,300 $336,000
Q1 2023 May 15, 2023	BUY	$36.99 - $48.71 $236,736 - $311,744	6,400 New	6,400 $247,000
Q1 2022 May 16, 2022	SELL	$62.2 - $84.4 $242,580 - $329,160	-3,900 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$73.71 - $87.86 $73,710 - $87,860	-1,000 Reduced 20.41%	3,900 $329,000
Q2 2021 Aug 06, 2021	BUY	$92.19 - $115.71 $451,731 - $566,979	4,900 New	4,900 $472,000

348

84.3M

675K

846K

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $2.45B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.